1. To prove that patients with ulcerative proctitis and proctosigmoiditis have impaired autonomic functions, i.e. increased sympathetic activity and/or reduced vagal tone. 2. To demonstrate inflammatory cytokine imbalance, i.e., increased pro-inflammatory cytokines. Presence of these abnormalities would make patients with ulcerative proctitis and proctosigmoiditis good candidates for future sacral nerve stimulation therapy.
Study Type
OBSERVATIONAL
Enrollment
20
In this study, an electrocardiogram signal will be recorded for 30 min in the fasting state, and blood samples for inflammatory cytokines analysis (7 ml) will be taken at the end of the ECG recording; fecal samples will be taken on the experimental day before the study. In addition, ulcerative colitis disease activity index will be assessed using the Mayo scoring system.
Johns Hopkins University
Baltimore, Maryland, United States
symptoms characteristics in ulcerative colitis patients
ulcerative colitis disease activity index will be assessed using the Mayo scoring system, which includes stool frequency, rectal bleeding, mucosal appearance at endoscopy and physician rating of disease activity. The patient will get a score from 0 to 20, with higher score indicating more severe disease.
Time frame: 1 day
autonomic profile characteristics in ulcerative colitis patients and healthy controls
heart rate variability indicating sympathetic and parasympathetic activity
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Granulocyte-colony stimulating factor (G-CSF)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Eotaxin
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -1α
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Leptin
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Macrophage Inflammatory Proteins (MIP) -1α
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -4
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -1β
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -2
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -6
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Epidermal growth factor (EGF)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -13
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -10
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -12p70
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Interferon gamma (IFNγ)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -5
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -17A
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, interleukin (IL) -18
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Monocyte Chemoattractant Protein-1 (MCP-1)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Interferon - induced protein 10 (IP-10),
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, growth regulated oncogene (GRO)/Keratinocyte chemoattractant KC/cytokine-induced neutrophil chemoattractant (CINC)-1
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Vascular endothelial growth factor (VEGF)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Fractalkine
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Lipopolysaccharide-induced CXC chemokine (LIX)
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Macrophage Inflammatory Proteins (MIP) -2
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, Tumor necrosis factor (TNF) α
Time frame: 1 day
inflammatory cytokine profile in ulcerative colitis patients and healthy controls
blood sample, RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted)
Time frame: 1 day
microbiota profile in ulcerative colitis patients and healthy controls
fecal sample microbiota analysis
Time frame: 1 day